A new non-Hodgkin's B-cell line (DoHH2) with a chromosomal translocation t(14;18)(q32;q21).

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Leukemia

• Publication date

  1991-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 1849602
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Direct sequence analysis of the 14q+ and 18q- chromosome junctions in follicular lymphoma.

  1990cited by this paper
• Translocation t(14;18) in B cell lymphomas as a cause for defective immunoglobulin production

  1989cited by this paper
• The reciprocal partners of both the t(14; 18) and the t(11; 14) translocations involved in B-cell neoplasms are rearranged by the same mechanism.

  1988cited by this paper
• Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

  1988cited by this paper
• Somatic changes in B-lymphoproliferative disorders (B-LPD) detected by DNA-fingerprinting.

  1988cited by this paper
• The establishment of cell lines from chronic B cell leukaemias: evidence of leukaemic origin by karyotypic abnormalities and Ig gene rearrangement.

  1988cited by this paper
• Mechanism of the t(14;18) chromosomal translocation: structural analysis of both derivative 14 and 18 reciprocal partners.

  1987cited by this paper
• T‐cell prolymphocytic leukemia with an unusual phenotype CD4+ CD8+

  1987cited by this paper
• Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification.

  1987cited by this paper
• Hypervariable ‘minisatellite’ regions in human DNA

  1985cited by this paper
• Persistent Epstein‐Barr virus infection and a histiocytic sarcoma in a renal transplant recipient

  1985cited by this paper
• Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18.

  1985cited by this paper
• Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18.

  1985cited by this paper
• Involvement of the bcl-2 gene in human follicular lymphoma.

  1985cited by this paper

• DLBCL Cells Emerge after CD19 CAR T Cells with Cross-Antigen Resistance and a Gene Signature Predictive of Clinical CAR T-cell Response

  2025cites this paper
• In Silico Identification and Functional Characterization of Genetic Variations across DLBCL Cell Lines

  2023cites this paper
• The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models

  2019cites this paper
• Genetic modification of primary human B cells generates translationally-relevant models of high-grade lymphoma

  2019cites this paper
• Screening human cell lines for viral infections applying RNA-Seq data analysis

  2019cites this paper
• Synthesis of breast cancer targeting conjugate of temporin‐SHa analog and its effect on pro‐ and anti‐apoptotic protein expression in MCF‐7 cells

  2018cites this paper
• IL-25 dampens the growth of human germinal center-derived B-cell non Hodgkin Lymphoma by curtailing neoangiogenesis

  2018cites this paper
• Identification of TRA‐1‐60‐positive cells as a potent refractory population in follicular lymphomas

  2018cites this paper
• hnRNP L‐dependent protection of normal mRNAs from NMD subverts quality control in B cell lymphoma

  2018cites this paper
• Studies of Bruton’s tyrosine kinase inhibitors in B-cell malignancies

  2018cites this paper
• Epstein–Barr virus (EBV) provides survival factors to EBV+ diffuse large B‐cell lymphoma (DLBCL) lines and modulates cytokine induced specific chemotaxis in EBV+ DLBCL

  2017cites this paper
• Performance of a Commercially Available MAL Antibody in the Diagnosis of Primary Mediastinal Large B-Cell Lymphoma

  2017cites this paper
• Segway 2.0: Gaussian mixture models and minibatch training

  2017cites this paper
• In vitro and in vivo activity of melflufen (J1)in lymphoma

  2016cites this paper
• from Multiple Myeloma Patients and Cell Lines

  2016cites this paper
• Malignant hematopoietic cell lines: in vitro models for double-hit B-cell lymphomas

  2016cites this paper
• Semi-automated genome annotation using epigenomic data and Segway

  2016cites this paper
• Revisiting Erk signaling following B cell antigen receptor activation by different stimulatory agents

  2016cites this paper
• CK1δ in lymphoma: gene expression and mutation analyses and validation of CK1δ kinase activity for therapeutic application

  2015cites this paper
• New class of compounds - variators - are reprogramming substrate specificity of H3K4me3 epigenetic marks reading PHD domain of BPTF protein

  2015cites this paper
• Interleukin-17A promotes the growth of human germinal center derived non-Hodgkin B cell lymphoma

  2015cites this paper
• New class of compounds - variators - are reprogramming substrate specificity of H4K12Ac, H4K16Ac and H4K20Ac epigenetic marks reading bromodomain of BPTF protein

  2015cites this paper
• High-Throughput RNA Sequencing-Based Virome Analysis of 50 Lymphoma Cell Lines from the Cancer Cell Line Encyclopedia Project

  2014cites this paper
• The effects of a histone deacetylase inhibitor on biological behavior of diffuse large B-cell lymphoma cell lines and insights into the underlying mechanisms

  2013cites this paper
• program outcome in follicular lymphomas treated with a rituximab-intensive Persistence of minimal residual disease in bone marrow predicts

  2013cites this paper
• Modulating the bone marrow microenvironment:the role of DLL4:Notch signaling and hypoxia

  2013cites this paper
• Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program.

  2013cites this paper
• xenografts in immunodeficient mice Live attenuated measles virus induces regression of human lymphoma

  2013cites this paper
• Use of in vitro primary culture models to investigate the activity of standard and novel therapies in haematological malignancies

  2013cites this paper
• Murine Models of B-Cell Lymphomas: Promising Tools for Designing Cancer Therapies

  2012cites this paper
• Mutation discovery and characterization in lymphoid neoplasms using massively parallel RNA and DNA sequencing

  2012cites this paper
• Which pro-survival Bcl-2 family members are required for lymphoma development and sustained lymphoma growth

  2011cites this paper
• Membrane-associated signaling in human B-lymphoma lines.

  2011cites this paper
• Bcl-xL deamidation in oncogenic tyrosine kinase signalling

  2011cites this paper
• retinamide and effect of deregulated bcl-2 Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl)

  2011cites this paper
• Heterogeneous expression and function of IL-21R and susceptibility to IL-21-mediated apoptosis in follicular lymphoma cells.

  2010cites this paper
• Simultaneous Evaluation of T- and B-Cell Clonality, t(11;14) and t(14;18), in a Single Reaction by a Four-Color Multiplex Polymerase Chain Reaction Assay and Automated High-Resolution Fragment Analysis

  2010cites this paper
• The role of epigenetic regulation in B-cell lymphomas

  2010cites this paper
• Detection of EBV, HBV, HCV, HIV-1, HTLV-I and -II, and SMRV in Human and Other Primate Cell Lines

  2010cites this paper
• Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays

  2010cites this paper
• Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL.

  2008cites this paper
• Combined Molecular Diagnosis of B-cell Lymphomas With t(11;14)(q13;q32) or t(14;18)(q32;q21) Using Multiplex- and Long Distance Inverse-Polymerase Chain Reaction

  2008cites this paper
• Cyclin-dependent kinase inhibitor seliciclib shows in vitro activity in diffuse large B-cell lymphomas

  2007cites this paper
• Chemosensitization of B-cell lymphomas by methylseleninic acid involves nuclear factor-kappaB inhibition and the rapid generation of other selenium species.

  2007cites this paper
• Downregulation of myc promoter-binding protein 1 (MBP-1) in growth-arrested malignant B cells.

  2007influential citation
• Synthesis and biodistribution of 3'-fluoro-5-[(131)I]iodo-2'-deoxyuridine: a comparative study of [(131)I]FLIdU and [(18)F]FLT.

  2007cites this paper
• Proteome‐ and microarray‐based expression analysis of lymphoma cell lines identifies a p53‐centered cluster of differentially expressed proteins in mantle cell and follicular lymphoma

  2007cites this paper
• Ar-(4-Hydroxyphenyl)retinamide Induces Apoptosis of Malignant Hemopoietic Cell Lines Including Those Unresponsive to Retinole Acid1

  2006cites this paper
• Screening far red probes for use on optical biochip devices

  2006cites this paper
• BCR‐bound antigen is targeted to exosomes in human follicular lymphoma B‐cells 1

  2006influential citation
• Limitations and practical procedure in BclII-Ig heavy chain gene rearrangement real-time quantitative polymerase chain reaction.

  2006cites this paper
• The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours.

  2006cites this paper
• Sample pooling in 2‐D gel electrophoresis: A new approach to reduce nonspecific expression background

  2006cites this paper
• Transformed diffuse large B‐cell lymphomas with gains of the discontinuous 12q12‐14 amplicon display concurrent deregulation of CDK2, CDK4 and GADD153 genes

  2006cites this paper
• Up-regulation of p21WAF1 expression is mediated by Sp1/Sp3 transcription factors in TGFbeta1-arrested malignant B cells.

  2006cites this paper
• Consultations in Molecular Diagnostics Limitations and Practical Procedure in BclII-Ig Heavy Chain Gene Rearrangement Real-Time Quantitative Polymerase Chain Reaction

  2006cites this paper
• Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomas.

  2005cites this paper
• Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas

  2005cites this paper
• Protein expression pattern distinguishes different lymphoid neoplasms

  2005cites this paper
• Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scid mice

  2005cites this paper
• Frequent Joining of Bcl-2 to a JH6 Gene in Hepatitis C Virus-Associated t(14;18)1

  2004cites this paper
• Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines.

  2004cites this paper
• Hepatitis C Virus-Associated t ( 14 ; 18 ) 6 Gene inHFrequent Joining of Bcl-2 to a J

  2004cites this paper
• TGFβ-mediated activation of Smad1 in B-cell non-Hodgkin's lymphoma and effect on cell proliferation

  2004cites this paper
• The bcl-2/JH gene rearrangement is undetectable in Hodgkin's lymphomas: results from the German Hodgkin trial

  2004cites this paper
• The effect of TGFbeta1 on the expression and phosphorylation of key cell-cycle regulators in malignant B cells.

  2004cites this paper
• Bcl-2 Protein Is Required for the Adenine/Uridine-rich Element (ARE)-dependent Degradation of Its Own Messenger*

  2003cites this paper
• Delayed expression of apoptosis in human lymphoma cells undergoing low-dose taxol-induced mitotic stress

  2003cites this paper
• Fluoro-3-Deoxythymidine ( [ 18 F ]-FLT ) as Positron Emission Tomography Tracer for Imaging Proliferation in a Murine B-Cell Lymphoma Model and in the Human Disease

  2003cites this paper
• 3'-[18F]fluoro-3'-deoxythymidine ([18F]-FLT) as positron emission tomography tracer for imaging proliferation in a murine B-Cell lymphoma model and in the human disease.

  2003cites this paper
• Synergistic effects of chemotherapeutic drugs in lymphoma cells are associated with down-regulation of inhibitor of apoptosis proteins (IAPs), prostate-apoptosis-response-gene 4 (Par-4), death-associated protein (Daxx) and with enforced caspase activation.

  2003cites this paper
• different sensitivity to glucocorticoid-induced apoptosis BCL-2 expression and mitochondrial activity in leukemic cells

  2002cites this paper
• Human Leukemia-lymphoma Cell Lines: Historical Perspective, State of the Art and Future Prospects

  2002cites this paper
• Cyclin D-cdk6 complex is targeted by p21(WAF) in growth-arrested lymphoma cells.

  2002cites this paper
• Absence of the t(14; 18) chromosomal translocation in primary cutaneous B‐cell lymphoma: reply from authors

  2002cites this paper
• JH probe real‐time quantitative polymerase chain reaction assay for Bcl‐2/IgH rearrangements

  2002cites this paper
• The relative role of peripheral blood and bone marrow for monitoring molecular evidence of disease in follicular lymphoma by quantitative real‐time polymerase chain reaction

  2002cites this paper
• DNA damage-induced intracellular zinc transients: correlation with cell cycle arrest and apoptosis in lymphoma cells

  2002cites this paper
• Authentication and Characterization

  2002cites this paper
• Antisense oligonucleotides as therapeutics for the treatment of aggressive breast cancer

  2002cites this paper
• DNA damage-induced [Zn(2+)](i) transients: correlation with cell cycle arrest and apoptosis in lymphoma cells.

  2002cites this paper
• Liposomal Delivery of Antisense Oligonucleotides for Efficient Downregulation of Bcl-2 and Induction of Apoptosis

  2002cites this paper
• Cytometry of antitumor drug-intracellular target interactions.

  2001cites this paper
• Single-tube two-round polymerase chain reaction using the LightCycler instrument.

  2001cites this paper
• Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc− cystine transporter: a new action for an old drug

  2001cites this paper
• Localisation of a novel region of recurrent amplification in follicular lymphoma to an approximately 6.8 Mb region of 13q32-33.

  2001cites this paper
• Localisation of a novel region of recurrent amplification in follicular lymphoma to an ∼6.8 Mb region of 13q32‐33

  2001influential citation
• Frequency o f t he Bcl-2/IgH Rearrangement i n N ormal Individuals: I mplications f or t he M onitoring o f D isease i n Patients W ith F ollicular L ymphoma

  2001cites this paper
• Frequency of the Bcl-2/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma.

  2001cites this paper
• Absence of the t(14;18) chromosomal translocation in primary cutaneous B‐cell lymphoma

  2001cites this paper
• Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice.

  2001cites this paper
• Cyclin A down-regulation in TGFbeta1-arrested follicular lymphoma cells.

  2000cites this paper
• Chemical Sensitization of Apoptosis Induced by Hyperthermia

  2000cites this paper
• Lineage-related sensitivity to apoptosis in human tumor cells undergoing hyperthermia

  2000cites this paper
• Differential sensitivity to etoposide (VP-16)-induced S phase delay in a panel of small-cell lung carcinoma cell lines with G1/S phase checkpoint dysfunction

  2000cites this paper
• Eradication of human non-Hodgkin's lymphoma in SCID mice by BCL-2 antisense oligonucleotides combined with low-dose cyclophosphamide.

  2000cites this paper
• Rapid-cycle PCR in temporarily compartmentalized capillaries: two-round PCR in a single capillary prevents product carry-over.

  2000cites this paper
• High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up.

  2000cites this paper
• A novel deep red/low infrared fluorescent flow cytometric probe, DRAQ5NO, for the discrimination of intact nucleated cells in apoptotic cell populations.

  2000cites this paper
• High-Dose T herapy W ith A utologous B one M arrow S upport as C onsolidation o f R emission i n F ollicular L ymphoma: Long-Term C linical a nd M olecular F ollow-Up

  2000cites this paper